AXGN · NASDAQ
Axogen (AXGN) Stock Price & Fundamentals
Axogen (AXGN) closed at $578.78 on Oct 9, 2026, up 1.45% from the previous close of $570.53.
Share price, past year
1Y +25.81%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $578.78 |
| Sep 30, 2026 | $547.73 |
| Aug 31, 2026 | $569.59 |
| Jul 31, 2026 | $553.68 |
| Jun 30, 2026 | $517.10 |
| May 29, 2026 | $520.97 |
| Apr 30, 2026 | $506.44 |
| Mar 31, 2026 | $532.46 |
| Feb 27, 2026 | $528.92 |
| Jan 30, 2026 | $514.86 |
| Dec 31, 2025 | $482.92 |
| Nov 28, 2025 | $471.26 |
| Oct 31, 2025 | $474.21 |
Key statistics
- Market cap
- $31.06B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.68
- Revenue (TTM)
- $251.17M
- Net income (TTM)
- −$33.55M
- Shares outstanding
- 53.7M
- Dividend yield
- —
- 52-week range
- $460.06 – $583.86
Axogen's market cap is $31.06B, based on a share price of $578.78 and 53.7M shares outstanding as of Jun 30, 2026.
Financials
Axogen reported revenue of $225.21M for fiscal 2025, up 20.21% from fiscal 2024.
Axogen reported a net loss of $15.70M in fiscal 2025.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $225.21M | +20.2% | −$15.70M | −7.0% | −$0.34 | −$2.93M |
| FY2024ended Dec 31, 2024 | $187.34M | +17.8% | −$9.96M | −5.3% | −$0.23 | $1.43M |
| FY2023ended Dec 31, 2023 | $159.01M | +14.7% | −$21.72M | −13.7% | −$0.51 | −$19.59M |
| FY2022ended Dec 31, 2022 | $138.58M | +8.8% | −$28.95M | −20.9% | −$0.69 | −$36.14M |
| FY2021ended Dec 31, 2021 | $127.36M | +13.4% | −$26.99M | −21.2% | −$0.65 | −$41.22M |
| FY2020ended Dec 31, 2020 | $112.30M | +5.2% | −$23.79M | −21.2% | −$0.60 | −$31.53M |
| FY2019ended Dec 31, 2019 | $106.71M | +27.1% | −$29.14M | −27.3% | −$0.74 | −$24.54M |
| FY2018ended Dec 31, 2018 | $83.94M | +38.9% | −$22.40M | −26.7% | −$0.60 | −$24.14M |
| FY2017ended Dec 31, 2017 | $60.43M | +47.0% | −$10.45M | −17.3% | −$0.31 | −$10.34M |
| FY2016ended Dec 31, 2016 | $41.11M | — | −$14.41M | −35.1% | −$0.47 | −$12.17M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $69.73M | −$1.52M | −$0.03 |
| Q1 FY2026ended Mar 31, 2026 | $61.46M | −$19.58M | −$0.38 |
| Q4 FY2025ended Dec 31, 2025 | $59.90M | −$13.16M | −$0.28 |
| Q3 FY2025ended Sep 30, 2025 | $60.08M | $708.00K | $0.01 |
| Q2 FY2025ended Jun 30, 2025 | $56.66M | $579.00K | $0.01 |
| Q1 FY2025ended Mar 31, 2025 | $48.56M | −$3.83M | −$0.08 |
| Q4 FY2024ended Dec 31, 2024 | $49.40M | $450.00K | $0.00 |
| Q3 FY2024ended Sep 30, 2024 | $48.64M | −$1.86M | −$0.04 |
Company profile
- Name
- Axogen, Inc.
- Ticker
- AXGN
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Electromedical & Electrotherapeutic Apparatus
- Headquarters
- 13631 Progress Blvd., Suite 400, Alachua, FL 32615
- Incorporated in
- MN
- Fiscal year ends
- December
- SEC CIK
- 0000805928
Recent SEC filings
- Oct 1, 2026
- Sep 10, 2026
- Jul 29, 2026
- Jul 29, 2026
- Jun 23, 2026
- Apr 28, 2026
- Apr 28, 2026
- Feb 24, 2026
Frequently asked questions
What is Axogen's stock price?
Axogen (AXGN) closed at $578.78 on Oct 9, 2026, up 1.45% from the previous close of $570.53.
What is Axogen's market cap?
Axogen's market cap is $31.06B, based on a share price of $578.78 and 53.7M shares outstanding as of Jun 30, 2026.
How much revenue does Axogen make?
Axogen reported revenue of $225.21M for fiscal 2025, up 20.21% from fiscal 2024.
Does Axogen pay a dividend?
Axogen's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Axogen, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures